Kian-Huat Lim, MD, PhD, discusses the importance of multidisciplinary collaboration when diagnosing and treating patients with pancreatic cancer.
Kian-Huat Lim, MD, PhD
Advertisement
Articles by Kian-Huat Lim, MD, PhD
Kian-Huat Lim, MD, PhD, discusses the current standard of care for patients with resectable or borderline resectable pancreatic cancer.
Kian-Huat Lim, MD, PhD, discusses factors influencing the choice between treatment with FOLFIRINOX or NALIRIFOX for metastatic pancreatic cancer.
Dr Lim on the Current Treatment Paradigm For Metastatic Pancreatic Cancer
Published: | Updated:
Kian-Huat Lim, MD, PhD, discusses the current treatment options for patients with metastatic pancreatic cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026
3
The OncFive: Top Oncology Articles for the Week of 5/31
4
FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer
5